Answers are grounded in this paper and cite their sources.
The results of our study showed that miR-491-3p could ameliorate biological characteristics of hFOB1.19 cells by reducing CTSS expression suggesting that miR-491-3p/CTSS might be a potential biomarker for the diagnosis and treatment of PMO.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: